Last published market research from plusdetudes.com related to Social protection. http://www.plusdetudes.com/ci0128/-market-research.html 2007-08-21T12:45:16Z IBISWORLD INDUSTRY MARKET RESEARCH REPORTThis is the replacement for IBISWorld's December 2006 edition of Health Insurance in Australia report.Industry Market Research SynopsisThis http://www.plusdetudes.com/p047293/Health-Insurance-in-Australia.html http://www.plusdetudes.com/p047293/Health-Insurance-in-Australia.html IntroductionAn in-depth analysis of the private medical insurance market in the UK, covering market size, key competitors, customer dynamics and forecasts.ScopeData and market research, including information on premium income, http://www.plusdetudes.com/p046704/UK-Private-Medical-Insurance-2006.html http://www.plusdetudes.com/p046704/UK-Private-Medical-Insurance-2006.html IBISWORLD INDUSTRY MARKET RESEARCH REPORTThis is the first publication of IBISWorld's Global Direct Life, Health and Medical Insurance Carriers report.Industry Market Research Synopsis http://www.plusdetudes.com/p045801/Global-Direct-Life-Health-and-Medical-Insurance-Carriers.html http://www.plusdetudes.com/p045801/Global-Direct-Life-Health-and-Medical-Insurance-Carriers.html IBISWORLD INDUSTRY MARKET RESEARCH REPORTThis is the replacement for IBISWorld's September 2006 edition of Direct Life, Health, and Medical Insurance Carriers in the US report.Industry Market Research Syn http://www.plusdetudes.com/p044922/Direct-Life-Health-and-Medical-Insurance-Carriers-in-the-US.html http://www.plusdetudes.com/p044922/Direct-Life-Health-and-Medical-Insurance-Carriers-in-the-US.html IntroductionThe government has relied on simple PandR tools to contain rising healthcare costs and provide a reasonable level of healthcare. However, factors such as a healthier elderly population are masking healthcare system inefficie http://www.plusdetudes.com/p040713/Pricing-and-Reimbursement-in-Japan-Costly-healthcare-system-inefficiencies-increase-the-focus-on-healthcare-cost-containment.html http://www.plusdetudes.com/p040713/Pricing-and-Reimbursement-in-Japan-Costly-healthcare-system-inefficiencies-increase-the-focus-on-healthcare-cost-containment.html IntroductionCombined drug sales in the five major European markets represent the second-biggest market globally after the US. Unlike the US, which is dominated by a wide range of private payers, governments are the major payers in Eur http://www.plusdetudes.com/p033553/Pricing-and-Reimbursement-in-Europe-Can-the-drive-for-cost-effectiveness-overcome-cost-containment.html http://www.plusdetudes.com/p033553/Pricing-and-Reimbursement-in-Europe-Can-the-drive-for-cost-effectiveness-overcome-cost-containment.html Pay for Performance (P4P) http://www.plusdetudes.com/p036474/Pay-for-Performance-P4P.html http://www.plusdetudes.com/p036474/Pay-for-Performance-P4P.html Case or Care Management http://www.plusdetudes.com/p036482/Case-or-Care-Management.html http://www.plusdetudes.com/p036482/Case-or-Care-Management.html This is the replacement to IBISWorld's May 2006 edition of Direct Life, Health, and Medical Insurance Carriers in the US report.This report from IBISWorld provides a detailed analysis of the Direct Life, Health, and Medical Insurance http://www.plusdetudes.com/p043061/Direct-Life-Health-and-Medical-Insurance-Carriers-in-the-US.html http://www.plusdetudes.com/p043061/Direct-Life-Health-and-Medical-Insurance-Carriers-in-the-US.html Since the mid-1990s, pharma companies have devised their sales and marketing strategies based on Rx data. However, with the introduction of the AMA’s Prescribing Data Restriction Program (PDRP) opt-out program in July 2006, pharma companies need to e http://www.plusdetudes.com/p045248/The-Prescribing-Data-Restriction-Program-Critical-Assessment-and-Best-Practices.html http://www.plusdetudes.com/p045248/The-Prescribing-Data-Restriction-Program-Critical-Assessment-and-Best-Practices.html